Eisai Co Company Top Insiders
| ESALF Stock | USD 28.50 1.50 5.56% |
Eisai Co employs about 11.3 K people. The company is managed by 10 executives with a total tenure of roughly 58 years, averaging almost 5.0 years of service per executive, having 1132.2 employees per reported executive. Examination of Eisai Co's management performance can provide insight into the company performance.
| Gary Hendler CEO Sr. VP, CEO of Eisai Europe Ltd and President of Eisai Europe Ltd and President of EMEA Region and President of Eisai Global Oncology Bus. Unit |
| Haruo Naito CEO CEO, Representative Corporate Officer and Director |
Eisai |
Eisai Co Management Team Effectiveness
Eisai Co's management efficiency ratios could be used to measure how well Eisai Co manages its routine affairs as well as how well it operates its assets and liabilities.Eisai Co holds a total of 286.7 Million outstanding shares. 30% of Eisai Co outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as Eisai Co in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Eisai Co, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Eisai Co Workforce Comparison
Eisai Co is one of the top stocks in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 201,341. Eisai Co holds roughly 11,322 in number of employees claiming about 6% of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of 0.04 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.01 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.01. Eisai Co Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Eisai Co Price Series Summation is a cross summation of Eisai Co price series and its benchmark/peer.
Eisai Co Notable Stakeholders
An Eisai Co stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Eisai Co often face trade-offs trying to please all of them. Eisai Co's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Eisai Co's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Gary Hendler | Sr. VP, CEO of Eisai Europe Ltd and President of Eisai Europe Ltd and President of EMEA Region and President of Eisai Global Oncology Bus. Unit | Profile | |
| Haruo Naito | CEO, Representative Corporate Officer and Director | Profile | |
| Kenta Takahashi | Sr. VP, Executive Director of Legal Department and General Counsel of Intellectual Property | Profile | |
| Tatsuyuki Yasuno | Executive Officer, Director of Corporate Planning & Strategy | Profile | |
| Sayoko Sasaki | Executive Officer, Director of PR, Manager of Global Access Strategies Office | Profile | |
| Yanhui Feng | Executive Officer, General Manager of Subsidiaries | Profile | |
| Nadeem Sarwar | President | Profile | |
| Yosuke Akita | Chief VP | Profile | |
| Teruyuki Masaka | VP Officer | Profile | |
| MD FAAN | VP Health | Profile |
About Eisai Co Management Performance
The success or failure of an entity such as Eisai Co often depends on how effective the management is. Eisai Co management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Eisai management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Eisai management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
It offers Aricept for the treatment of alzheimers diseasedementia with Lewy bodies Methycobal for the treatment of peripheral neuropathy and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan. Eisai operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 11322 people.
Eisai Co Workforce Analysis
Traditionally, organizations such as Eisai Co use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Eisai Co within its industry.Eisai Co Manpower Efficiency
Return on Eisai Co Manpower
| Revenue Per Employee | 66.8M | |
| Revenue Per Executive | 75.6B | |
| Net Income Per Employee | 4.2M | |
| Net Income Per Executive | 4.8B | |
| Working Capital Per Employee | 28M | |
| Working Capital Per Executive | 31.7B |
Complementary Tools for Eisai Pink Sheet analysis
When running Eisai Co's price analysis, check to measure Eisai Co's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eisai Co is operating at the current time. Most of Eisai Co's value examination focuses on studying past and present price action to predict the probability of Eisai Co's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eisai Co's price. Additionally, you may evaluate how the addition of Eisai Co to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |